GRISEOFULVIN COMPOUND AND ITS PHARMACEUTICAL APPLICATION Russian patent published in 2022 - IPC C07D307/94 A61K31/343 A61K31/351 A61K31/4155 A61K31/424 A61K31/4245 A61K31/438 A61K31/443 A61K31/454 A61K31/506 A61P3/04 A61P21/02 A61P25/00 A61P25/02 A61P25/08 A61P25/14 A61P25/16 A61P29/00 

Abstract RU 2774618 C2

FIELD: pharmaceutics.

SUBSTANCE: invention relates to griseofulvin derivatives, a pharmaceutical composition based on them, as well as to the use of a pharmaceutical composition for the prevention and/or treatment of an inflammatory disease of the central nervous system. The composition contains a compound of the general formula (1’) or its pharmacologically acceptable salt, where R1 is a C1-C6 alkyl group optionally substituted with the same or different one or two substituents selected from a substituent X group, R2 is a C1-C6 alkyl group, A is a 5-element aromatic heterocyclic ring selected from pyrazolyl and oxadiazolyl, a 6-element aromatic heterocyclic ring selected from pyridinyl and pyrimidinyl, or a single bond (if a single bond, then one or the other of R3 and R3’ is absent); R3 and R3’, each independently, is a hydrogen atom, a hydroxy group, a C1-C6 alkyl group optionally substituted with the same or different one or two substituents selected from the substituent X group, a C1-C6 alkoxy group optionally substituted with the same or different one or two substituents selected from the substituent X group, a 6-element aromatic heterocyclic group selected from piperidinyl and tetrahydropyranyl, optionally substituted with the same or different one or two substituents selected from the substituent X group, or R3 and R3’ can form a 6-element unsaturated heterocyclic ring as a ring that binds and condenses with A, and the specified ring is optionally substituted with the same or different one or two substituents selected from the substituent X group, the substituent X group is a halogen atom, a hydroxy group, C1-C6 alkyl group, C1-C6 alkoxy group.

EFFECT: new compounds are obtained, as well as a pharmaceutical composition based on them, which can be used in medicine for the treatment of an inflammatory disease of the central nervous system.

17 cl, 4 dwg, 17 tbl, 25 ex

Similar patents RU2774618C2

Title Year Author Number
GRISEOFULVIN COMPOUND 2017
  • Saito, Keiji
  • Nakajima, Katsuyoshi
  • Taniguchi, Toru
  • Iwamoto, Osamu
  • Shibuya, Satoshi
  • Ogawa, Yasuyuki
  • Aoki, Kazumasa
  • Kurikawa, Nobuya
  • Tanaka, Shinji
  • Ogitani, Momoko
  • Kioi, Eriko
  • Ito, Kaori
  • Nishihama, Natsumi
  • Mikkaichi, Tsuyoshi
  • Saitoh, Wataru
RU2736208C2
CYCLIC DIONES AS HERBICIDAL COMPOUNDS 2020
  • Hennessy Alan Joseph
  • Jones Elizabeth Pearl
  • Dale Suzanna Jane
  • Gregory Alexander William
  • Houlsby Ian Thomas Tinmouth
  • Bhonoah Yunas
  • Comas-Barcelo Julia
  • Elves Philip Michael
RU2822391C2
SULPHONAMIDE COMPOUND OR SALT THEREOF 2017
  • Miyahara, Seiji
  • Ueno, Hiroyuki
  • Hara, Shoki
  • Ogino, Yoshio
RU2732572C2
2-METHOXYIMINOPHENYLACETIC ACID ORTHO-SUBSTITUTED AMIDES, METHOD OF THEIR SYNTHESIS, AGENT FOR HARMFUL FUNGI CONTROL AND INSECTOACARICIDE AGENT 1994
  • Rajnkhard Kirstgen
  • Vassilios Grammenos
  • Gerbert Bajer
  • Rajnkhard Dettser
  • Khartmann Kenig
  • Klaus Oberdorf
  • Khubert Zauter
  • Khorst Vingert
  • Gizela Lorents
  • Ehberkhard Ammermann
  • Folker Kharries
RU2130924C1
ANTITUMOR AGENT 2018
  • Ueno, Hiroyuki
  • Hoshino, Takuya
RU2770824C2
AZAINDOLE DERIVATIVE 2015
  • Nakamura, Masayuki
  • Yamanaka, Khirojosi
  • Sibata, Kadzuaki
  • Mitsuya, Morikhiro
  • Kharada, Takafumi
RU2649575C1
CYCLIC CYANOENONE DERIVATIVES AS KEAP1 MODULATORS 2021
  • Altman, Michael
  • Candito, David, A.
  • Christian, Alec, H.
  • Di Pietro, Ornella
  • Lu, Min
  • Liu, Ping
  • Mansoor, Umar, Faruk
  • Mennie, Katrina, Marie
  • Musacchio, Andrew, J.
  • Palani, Anandan
  • Reutershan, Michael, H.
  • Shaw, David, Matthew
  • St-Gallay, Stephen
RU2822828C1
CONDENSED QUINOLINE DERIVATIVE AND USE THEREOF 2005
  • Kadzino Masakhiro
  • Kherd Nikolas Uill'Jam
  • Tarui Naoki
  • Banno Khirosi
  • Kavano Jasukhiko
  • Inatomi Nobukhiro
RU2384571C2
HETEROAROMATIC MODULATORS OF RETINOL-BOUND ORPHAN GAMMA RECEPTOR 2017
  • Jessiman, Alan Stuart
  • Johnson, Patrick Stephen
  • Maansson, Kristoffer
  • Sorensen, Morten Dahl
RU2771280C2
AGENT FOR PROPHYLAXIS AND TREATMENT OF NEUROPATHY 2003
  • Momose Jju
  • Sakai Nozomu
  • Maekava Tsujosi
  • Khazama Masatosi
  • Kavamura Toru
  • Sera Misajo
RU2337682C2

RU 2 774 618 C2

Authors

Saito, Keiji

Nakajima, Katsuyoshi

Ogawa, Yasuyuki

Makino, Mitsuhiro

Ito, Kaori

Nagata, Seiko

Hirasawa, Makoto

Dates

2022-06-21Published

2018-09-28Filed